DDVAX Performance — Nomura Value Fund, Class A
Data updated: 2026-07-27
DDVAX returned +5.78% year to date and +17.51% over one year to May 2026. Annualised returns are +10.65% over 3 years and +5.40% over 5 years. The fund trailed its US Large Value category average: $100 invested three years ago grew to $135, against $165 for the category, and to $118 over one year, against $124. Volatility over the past three years was 12.37% a year. In the 12 months to May 2026 the fund lost a net $363.3M, and assets reached $1.76B.
DDVAX Growth of $100
What $100 invested in Nomura Value Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the US Large Value category average over the same months.
| Period | DDVAX | Category average |
|---|---|---|
| 1 year (Jun 2025 – May 2026) | $118 | $124 |
| 3 years (Jun 2023 – May 2026) | $135 | $165 |
| 5 years (Jun 2021 – May 2026) | $130 | $163 |
| Since data start (Sep 2019 – May 2026) | $165 | $223 |
DDVAX Trailing Returns
Total returns to May 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +5.78% |
| 1 year | +17.51% |
| 3 years (annualised) | +10.65% |
| 5 years (annualised) | +5.40% |
DDVAX Annual Returns
Calendar-year total returns of Nomura Value Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–May) | +5.78% |
| 2025 | +10.57% |
| 2024 | +6.69% |
| 2023 | +1.84% |
| 2022 | −3.77% |
| 2021 | +22.10% |
| 2020 | −0.13% |
| 2019 (Sep–Dec) | +10.37% |
DDVAX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +5.3% | +3.9% | −6.0% | +4.7% | −1.8% | — | — | — | — | — | — | — |
| 2025 | +2.2% | +0.8% | −3.0% | −3.9% | +3.7% | +2.6% | +1.2% | +3.6% | +0.1% | −0.5% | +2.9% | +0.8% |
| 2024 | −0.4% | +3.5% | +5.1% | −4.9% | +0.6% | −0.5% | +4.6% | +2.3% | +1.5% | −2.3% | +5.4% | −7.4% |
| 2023 | +3.0% | −4.1% | −2.8% | +2.3% | −4.5% | +5.3% | +2.6% | −3.0% | −5.0% | −0.8% | +4.9% | +4.8% |
| 2022 | −0.5% | −0.9% | +1.6% | −5.2% | +2.2% | −7.4% | +4.2% | −2.4% | −7.4% | +11.6% | +5.3% | −3.3% |
| 2021 | −1.7% | +3.4% | +7.2% | +2.8% | +2.5% | −2.3% | +1.1% | +1.2% | −2.3% | +4.1% | −3.1% | +7.9% |
| 2020 | −2.8% | −11.4% | −14.9% | +11.7% | +4.4% | −1.1% | +2.4% | +2.7% | −2.2% | −2.9% | +13.6% | +4.2% |
| 2019 | — | — | — | — | — | — | — | — | +3.9% | +0.1% | +2.6% | +3.4% |
DDVAX Risk
Risk measures from monthly returns over Jun 2023 – May 2026.
- 3-year volatility (annualised): 12.37%
- 3-year Sharpe ratio: 0.50 (vs 4.5% risk-free rate)
- Best month: +5.39% (Nov 2024)
- Worst month: −7.44% (Dec 2024)
DDVAX Fund Flows
Monthly money in and out of Nomura Value Fund, from SEC Form N-PORT.
- 12-month net flow: −$363.3M
- 12-month gross sales (incl. reinvestments): $565.3M
- Sales ÷ redemptions: 0.61×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| May 2026 | $7.4M | $51.0M | −$43.6M |
| Apr 2026 | $6.3M | $48.9M | −$42.6M |
| Mar 2026 | $13.9M | $57.0M | −$43.1M |
| Feb 2026 | $16.5M | $61.1M | −$44.6M |
| Jan 2026 | $16.7M | $65.1M | −$48.4M |
| Dec 2025 | $431.0M | $158.0M | $273.0M |
| Nov 2025 | $7.0M | $86.8M | −$79.8M |
| Oct 2025 | $10.4M | $75.1M | −$64.7M |
| Sep 2025 | $12.4M | $73.2M | −$60.8M |
| Aug 2025 | $7.2M | $86.9M | −$79.7M |
| Jul 2025 | $18.8M | $78.3M | −$59.5M |
| Jun 2025 | $17.7M | $87.1M | −$69.4M |
DDVAX Assets Under Management
Net assets of Nomura Value Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-05-29 | $1.76B |
| 2026-02-27 | $1.96B |
| 2025-11-28 | $2.01B |
| 2025-08-29 | $2.17B |
| 2025-05-30 | $2.23B |
| 2025-02-28 | $2.77B |
| 2024-11-29 | $3.37B |
| 2024-08-30 | $3.56B |
| 2024-05-31 | $3.71B |
| 2024-02-29 | $3.98B |
| 2023-11-30 | $4.58B |
| 2023-08-31 | $5.44B |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.